The DSMB operates independently of the study sponsors and investigators to maintain objectivity. They meet at predefined intervals to review accumulated data, which can include safety reports, adverse event logs, and preliminary efficacy data. Based on this review, they can recommend changes to the study protocol or even halt the trial if necessary. All their findings and recommendations are documented and communicated to the trialâs sponsor and regulatory authorities.